These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2621111)

  • 1. Serotonergic denervation does not reduce brain uptake of n-isopropyl-p-[123I]iodoamphetamine in vivo.
    de Jong BM; Ruijter JM; Van der Woude TP; Mirmiran M; van Royen EA
    Int J Rad Appl Instrum B; 1989; 16(8):753-7. PubMed ID: 2621111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of N-isopropyl-[125I]p-iodoamphetamine affinity sites in rat brain by autoradiography.
    Kondoh Y; Murakami M; Takahashi K; Itoh I; Mizusawa S; Nakamichi H; Sasaki H; Watanabe K; Tagawa K; Uemura K
    Tohoku J Exp Med; 1986 Jun; 149(2):229-30. PubMed ID: 2875546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High uptake of N-isopropyl-p-[123I]-iodoamphetamine (123I-IMP) demonstrated by dynamic SPECT in some cases of glioma].
    Sugou N; Shibata I; Nemoto A; Nemoto M; Ohishi H; Kuroki T; Seiki Y; Terao H; Takahashi H; Takano M; Takahashi M
    Kaku Igaku; 1996 Jul; 33(7):695-704. PubMed ID: 8803437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin uptake in cerebral cortex cultures: imipramine-like inhibition by N-isopropyl-p-iodoamphetamine.
    de Jong BM; Feenstra MG; Ruijter JM; van Royen EA
    Exp Neurol; 1989 Mar; 103(3):297-9. PubMed ID: 2920796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on liver accumulation of N-isopropyl-p-iodoamphetamine].
    Kosuda S; Kawahara S; Ishibashi A; Tamura K; Kubo A; Hashimoto S
    Kaku Igaku; 1990 Jun; 27(6):599-605. PubMed ID: 2214325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in biodistribution of 11C-methamphetamine (MAP), 14C-MAP, and 123I-N-isopropyl-iodoamphetamine (IMP) in MAP- and cocaine-sensitized animals.
    Numachi Y; Yoshida S; Inosaka T; Sato M; Mizugaki M; Kimura K; Hishinuma T
    Ann N Y Acad Sci; 1992 Jun; 654():153-9. PubMed ID: 1632580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-isopropyl-123I-p-iodoamphetamine uptake mechanism in the lung--is it dependent on pH, lipophilicity or pKa?
    Akber SF
    Nuklearmedizin; 1991 Dec; 30(6):294-6. PubMed ID: 1780245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration and quantitation of pharmacological inhibition of pulmonary uptake of N-isopropyl-123I-p-iodoamphetamine by propranolol.
    Akber SE
    Nuklearmedizin; 1989 Jun; 28(3):100-4. PubMed ID: 2740249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal changes in accumulation of N-isopropyl-p-iodoamphetamine in human brain: relation to lung clearance.
    Yonekura Y; Fujita T; Nishizawa S; Iwasaki Y; Mukai T; Konishi J
    J Nucl Med; 1989 Dec; 30(12):1977-81. PubMed ID: 2585099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study on N-isopropyl-p-iodoamphetamine lung uptake].
    Kosuda S; Kawahara S; Ishibashi A; Tamura K; Kubo A; Hashimoto S
    Kaku Igaku; 1990 Feb; 27(2):149-53. PubMed ID: 2348584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo chemistry of iofetamine HCl iodine-123 (IMP).
    Baldwin RM; Wu JL
    J Nucl Med; 1988 Jan; 29(1):122-4. PubMed ID: 3335919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of N-isopropyl-p-iodoamphetamine in mice.
    Hoshi H; Jinnouchi S; Watanabe K; Ueda T; Kinoshita K; Yamaguchi T; Tahara Y
    Int J Rad Appl Instrum B; 1988; 15(2):127-31. PubMed ID: 3366615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cigarette smoking on iodine 123 N-isopropyl-p-iodoamphetamine clearance from the lung.
    Kato K; Harada S; Takahashi T; Katsuragawa S; Yanagisawa T
    Eur J Nucl Med; 1991; 18(10):801-5. PubMed ID: 1743202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thallium-201 diethyldithiocarbamate: an alternative to iodine-123 N-isopropyl-p-iodoamphetamine.
    de Bruine JF; van Royen EA; Vyth A; de Jong JM; van der Schoot JB
    J Nucl Med; 1985 Aug; 26(8):925-30. PubMed ID: 2993550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of 123I IMP retention in the lung and application to the diagnosis of lung disease].
    Ikeda H; Komatsu M; Takahashi K; Yasui S; Mariko M
    Rinsho Hoshasen; 1990 Feb; 35(2):243-7. PubMed ID: 2325284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of ocular melanoma with N-isopropyl-p-[123I]-iodoamphetamine.
    Ono S; Fukunaga M; Otsuka N; Nagai K; Morita K; Furukawa T; Muranaka A; Yanagimoto S; Tomomitsu T; Tabuchi A
    J Nucl Med; 1988 Aug; 29(8):1448-50. PubMed ID: 3404259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-isopropyl-4-[123I]iodoamphetamine (123I-IMP) products: a difference in radiochemical purity, unmetabolized fraction, and octanol extraction fraction in arterial blood and regional brain uptake in rats.
    Kanai Y; Hasegawa S; Kimura Y; Oku N; Ito H; Fukuda H; Hatazawa J
    Ann Nucl Med; 2007 Sep; 21(7):387-91. PubMed ID: 17876551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [123I-N-isopropyl-p-iodoamphetamine scintigraphy in patients with malignant melanoma].
    Nakabeppu Y; Nakajo M; Iwashita S; Tanoue T; Shinohara S
    Radioisotopes; 1990 Apr; 39(4):163-7. PubMed ID: 2345790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional dynamics of N-isopropyl-(123I)p-iodoamphetamine in human brain.
    Nishizawa S; Tanada S; Yonekura Y; Fujita T; Mukai T; Saji H; Fukuyama H; Miyoshi T; Harada K; Ishikawa M
    J Nucl Med; 1989 Feb; 30(2):150-6. PubMed ID: 2786930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the binding of N-isopropyl-p-[125I]iodoamphetamine in the rat brain synaptosomal membranes.
    Mori H; Shiba K; Matsuda H; Tsuji S; Hisada K
    Nucl Med Commun; 1990 Apr; 11(4):327-31. PubMed ID: 2362745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.